These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Yonemura Y; Ku H; Hirayama F; Souza LM; Ogawa M Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4040-4. PubMed ID: 8633013 [TBL] [Abstract][Full Text] [Related]
5. [Interleukin-3: a preclinical study]. Valent P; Geissler K; Bettelheim P Wien Klin Wochenschr; 1989 Oct; 101(19):652-63. PubMed ID: 2482586 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF): two cytokines increasing histamine synthesis by hematopoietic cells. Dy M; Schneider E Eur Cytokine Netw; 1991; 2(3):153-72. PubMed ID: 1716491 [No Abstract] [Full Text] [Related]
7. New role for histamine in interleukin-3-induced proliferation of hematopoietic stem cells. Schneider E; Piquet-Pellorce C; Dy M J Cell Physiol; 1990 May; 143(2):337-43. PubMed ID: 1970573 [TBL] [Abstract][Full Text] [Related]
8. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities. Emerson SG; Yang YC; Clark SC; Long MW J Clin Invest; 1988 Oct; 82(4):1282-7. PubMed ID: 3049674 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933 [TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. Gillio AP; Gasparetto C; Laver J; Abboud M; Bonilla MA; Garnick MB; O'Reilly RJ J Clin Invest; 1990 May; 85(5):1560-5. PubMed ID: 2332507 [TBL] [Abstract][Full Text] [Related]
11. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration. Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [TBL] [Abstract][Full Text] [Related]
13. Study of early hematopoietic precursors in human cord blood. Abboud M; Xu F; LaVia M; Laver J Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782 [TBL] [Abstract][Full Text] [Related]
14. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3. Schweiger A; Stern D; Lohman IC; Baldini M; Martinez FD; Halonen M J Allergy Clin Immunol; 2001 Mar; 107(3):505-10. PubMed ID: 11240952 [TBL] [Abstract][Full Text] [Related]
15. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. Sugiura K; Ikehara S; Inaba M; Haraguchi S; Ogata H; Sardiña EE; Sugawara M; Ohta Y; Good RA Exp Hematol; 1992 Feb; 20(2):256-63. PubMed ID: 1531958 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF. van Gils FC; Budel LM; Burger H; van Leen RW; Löwenberg B; Wagemaker G Exp Hematol; 1994 Mar; 22(3):248-55. PubMed ID: 7509288 [TBL] [Abstract][Full Text] [Related]
17. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site. Graham GJ; Wilkinson PC; Nibbs RJ; Lowe S; Kolset SO; Parker A; Freshney MG; Tsang ML; Pragnell IB EMBO J; 1996 Dec; 15(23):6506-15. PubMed ID: 8978677 [TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Ruggieri L; Heimfeld S; Broxmeyer HE Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350 [TBL] [Abstract][Full Text] [Related]
19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]